Home | MyGov

Accessibility
Accessibility Tools
Color Adjustment
Text Size
Navigation Adjustment
Screen Reader iconScreen Reader

Regulation of Drugs, Food and Medical Practice

Regulation of Drugs, Food and Medical Practice
Start Date :
Jun 10, 2015
Last Date :
Aug 11, 2015
00:00 AM IST (GMT +5.30 Hrs)
Submission Closed

This discussion theme is in continuance to our first discussion titled ‘Health System in India: Bridging the Gap between Potential and Performance’. To review what others have ...

This discussion theme is in continuance to our first discussion titled ‘Health System in India: Bridging the Gap between Potential and Performance’. To review what others have commented on this subject earlier in the first discussion, visit our Blog.

How can we maximize health returns through strengthening Regulation of Drugs, Food and Medical Practice?

1. Issues

1.1. Irrational prescription practices for drugs and diagnostics leads to overuse and wastage, as well as drug resistance.

1.2. Aggressive marketing and promotion activities of pharmaceutical companies augment irrational use of drugs.

1.3. There is concurrent jurisdiction of the Centre and States over drug regulation leading to dilution of accountability.

1.4. There are no regulations to control the sale and consumption of unhealthy foods in the population, particularly among children.

1.5. There is a lack of regulation to address the deficit of doctors in rural areas.

1.6. Irrational practices in clinical care continue because of non-adoption of standards of care and limited adoption by States of the Clinical Establishments Act (CEA).

2. Suggestions

2.1. The Standard treatment guidelines should be completed, widely disseminated, mandated and followed to promote rational prescription practices.

2.2. There should be effective enforcement of the guidelines on sale and prescription of drugs, especially antibiotics.

2.3. A mandatory code for identifying and penalizing unethical promotion by pharmaceutical companies is required to be developed.1 This includes legislation requiring drug companies to disclose payments made to doctors for research, lectures, consulting, travel and entertainment that may lead to conflicts of interest.

2.4. Systems of drug regulation need to be reformed since it is under the overlapping jurisdiction of Centre and States.

2.5. Suitable regulation to prevent the sale and consumption of unhealthy foods, particularly among school going children, must be in place.

2.6. There should be an appropriate regulatory mechanism to ensure compulsory rural service by medical graduates.

2.7. The conflict of interest arising due to private practice by Government doctors must be addressed through appropriate regulation.

2.8. The adoption and implementation of the Clinical Establishments Act which includes registration, standards of care, patient rights and grievance redressal mechanisms must be encouraged. Provisions to ensure these regulatory measures may be suitably incorporated into the MoU signed by States with the Centre.

2.9. Prescription audits may be undertaken by professional councils and faculty in medical colleges to ensure clinical decision making complies to evidence based protocols for care, thereby protecting patients from irrational practices.

Reset
Showing 131 Submission(s)
preethapremjith@gmail.com
Preetha P S 9 years 8 months ago

Patients with cancer, diabetes or other deadly diseases are their first target. Some are administering variety medicines to the patients without analysing the disease. So make provisions to analyse the prescription of these doctors if you can. Along with
adulteration practicing pharmacokinetics by the doctors for monetary benefit is also a menace to the society

preethapremjith@gmail.com
Preetha P S 9 years 8 months ago

Doctors are paying a lot by these companies. Make a list of Doctors present their research papers in International journals or International seminars. All the expenses were meet by these companies. If you go through the research papers or international
journeys of the doctors or the doctors with collaborative research with multinational companies it will be clear. Then go through their financial background and the details of the patients to clarify it.

preethapremjith@gmail.com
Preetha P S 9 years 8 months ago

Modiji,Another important thing that I noticed was doctors are working as agents for practicing pharmacokinetics of various drug.These multinational companies are doing their drug trials in common man especially in poor people. They make their trials even in small children. A number of doctors working in govt. as well as reputed private hospitals are doing collaborative research with multinational companies & trials of their vaccines are carried out in people esp. in poor.

cmchordia.jodhpur@gmail.com
Chanchal MAl Chordia 9 years 8 months ago

By neglecting Supporting Diseases, Diagnosis can not be correct and the Treatment based on such Diagnosis may give only Relief with Adverse Effect so what ever medicines is given to any Patient must be based on individual requirement because no two patients are exactly identical.

377_0
vjanani88@gmail.com
Janani Vedapuri 9 years 8 months ago

Government tested Maggie noodles and banned. I request to screen or random sample Ayurvedic products and regulate the standards . This is going to protect lot of women from getting affected .( Have faith in you MODI ji. VandeMataram)